Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors

Published:2021-07-01 Issue:7 Volume:7 Page:1051
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Hauth Franziska¹²,Ho Alice Y.¹,Ferrone Soldano³,Duda Dan G.¹

Affiliation:

1. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

2. Department of Radiation Oncology, University Clinic Tuebingen, Tuebingen, Germany

3. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2778656/jamaoncology_hauth_2021_rv_210001_1626360244.76315.pdf

Reference75 articles.

1. Engineering CAR-T cells for improved function against solid tumors.;Morgan;Front Immunol,2018

2. Adoptive cell therapy—harnessing antigen-specific T cells to target solid tumours.;Chrusciel;Cancers (Basel),2020

3. Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen.;Gong;Neoplasia,1999

4. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.;Maher;Nat Biotechnol,2002

5. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.;Eshhar;Proc Natl Acad Sci U S A,1993

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting hematological malignancies with isoxazole derivatives;Drug Discovery Today;2024-08

2. Pushing the CART to the Finish Line: Integrating Radiation Therapy Into Chimeric Antigen Receptor T-Cell Therapy Programs to Improve Outcomes for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma;International Journal of Radiation Oncology*Biology*Physics;2024-04

3. Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances;Journal of Controlled Release;2024-04

4. Current approaches in glioblastoma multiforme immunotherapy;Clinical and Translational Oncology;2024-03-21

5. MNK: A Novel Promising Target for Cancer Immunotherapy;Current Medicinal Chemistry;2024-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3